EUVIMEDEUVIMED entdecken
Crossref

Multivariate-Activated DNA Logic Gate for Predicting Responses to Cisplatin-Based Chemotherapy

Bin Li, Jueyue Yan, Danyang Wang, Xiao Li, Xueling Liu, Yuxi Ding, Feng Zhao, Yingcong Fan, Jiayi Yin iD, Yaokun Xia iD

Analytical Chemistry · 2026

DOI: 10.1021/acs.analchem.6c04574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Bin Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou310003, China. Hauptthemen laut MEDLINE: Cisplatin, Antineoplastic Agents, DNA, Computers, Molecular. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin-based chemotherapy remains an attractive alternative for controlling advanced cancers. However, a subset of cancer patients exhibits resistance to cisplatin. Accurate and early prediction of individual responses to cisplatin treatment is critical to personalized medicine guidance. The development of an effective method to predict chemotherapy response in cancer patients still faces challenges. Based on extracellular lactate, a key indicator of cisplatin resistance, herein, we report a multivariate-activated DNA logic gate to achieve lactate imaging with high fidelity. This device is assembled by a PNA–peptide–PNA copolymer and a lactate-specific aptamer with a cell membrane-anchoring aptamer module. It operates in response to the matrix metalloproteinase in the tumor microenvironment (TME) after the device anchors to nucleolin; thereby, the liberated aptamer binds to lactate through structure switching, achieving “off–on” fluorescence imaging. Additionally, imaging characteristics in combination with the Logistic Regression algorithm enable noninvasive prediction of cancer responses to cisplatin-based chemotherapy. In 90 cisplatin-resistant tumor-bearing mice, this detection model effectively identifies 77 of the 90 samples, showing a satisfactory accuracy of 85.6%. We further monitor the lactate level decreases in the TME using our method after the drug-resistant tumor-bearing mice treatment by stiripentol and successfully predict the enhancement of the therapeutic effect and the extension of the survival period. This study highlights the combined power of the DNA logic gate and machine learning for the analysis of lactate, paving the way for clinical cisplatin resistance detection and facilitating the formulation of personalized medicine guidance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinAntineoplastic AgentsDNAComputers, MolecularAnimalsAptamers, NucleotideHumansMiceLactic AcidDrug Resistance, NeoplasmTumor MicroenvironmentPeptide Nucleic AcidsOptical ImagingCell Line, Tumor

Substanzen

CisplatinAntineoplastic AgentsAptamers, NucleotideLactic AcidDNAPeptide Nucleic Acids

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou310003, China.
  • Intensive Care Unit, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou310003, China.
  • Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou310003, China.
  • Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou310003, China.
  • School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou310013, China.
  • Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou310003, China.

ORCID-Profile: Jiayi Yin, Yaokun Xia

Förderung

  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Li, B., Yan, J., Wang, D., Li, X., Liu, X., Ding, Y., Zhao, F., Fan, Y., Yin, J., & Xia, Y. (2026). Multivariate-Activated DNA Logic Gate for Predicting Responses to Cisplatin-Based Chemotherapy. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c04574

Vancouver

Li B, Yan J, Wang D, Li X, Liu X, Ding Y, et al. Multivariate-Activated DNA Logic Gate for Predicting Responses to Cisplatin-Based Chemotherapy. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c04574

BibTeX
@article{Li2026,
  author = {Li, Bin and Yan, Jueyue and Wang, Danyang and Li, Xiao and Liu, Xueling and Ding, Yuxi and Zhao, Feng and Fan, Yingcong and Yin, Jiayi and Xia, Yaokun},
  title = {Multivariate-Activated DNA Logic Gate for Predicting Responses to Cisplatin-Based Chemotherapy},
  journal = {Analytical Chemistry},
  year = {2026},
  doi = {10.1021/acs.analchem.6c04574}
}
Kostenlos starten →